IRADIMED CORPORATION Available-for-sale Securities, Gross Unrealized Gain
IRADIMED CORPORATION (IRMD) reported Available-for-sale Securities, Gross Unrealized Gain of $1.45 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2018-03-08
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for the quarter ending 2017-12-31 was -$3.76K.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for the quarter ending 2017-09-30 was $330.00.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for the quarter ending 2017-06-30 was $2.49K, a 77.27% decline year-over-year.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for the quarter ending 2017-03-31 was $2.39K, a 72.77% decline year-over-year.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for fiscal 2017 was $1.45K, a 44.67% decline from fiscal 2016.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for fiscal 2016 was $2.63K.
- IRADIMED CORPORATION available-for-sale securities, gross unrealized gain for fiscal 2013 was $1.42K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$3.76K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$3.43K derived: sum of 2 quarters · filed 2018-03-08 | -$937.00 derived: sum of 3 quarters · filed 2018-03-08 | $1.45K 10-K · filed 2018-03-08 |
| 2017-09-30 | $330.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $2.82K derived: sum of 2 quarters · filed 2017-11-06 | $5.21K 10-Q · filed 2017-11-06 | -$3.02K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $2.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $4.88K 10-Q · filed 2017-08-04 | -$3.35K derived: sum of 3 quarters · filed 2018-03-08 | -$12.24K derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $2.39K 10-Q · filed 2017-05-05 | -$5.85K derived: sum of 2 quarters · filed 2018-03-08 | -$14.73K derived: sum of 3 quarters · filed 2018-03-08 | -$3.76K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | -$8.24K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$17.12K derived: sum of 2 quarters · filed 2018-03-08 | -$6.15K derived: sum of 3 quarters · filed 2018-03-08 | $2.63K 10-K · filed 2018-03-08 |
| 2016-09-30 | -$8.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $2.09K derived: sum of 2 quarters · filed 2016-11-04 | $10.86K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $10.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $19.75K 10-Q · filed 2016-08-05 | ||
| 2016-03-31 | $8.78K 10-Q · filed 2016-05-06 | |||
| 2015-09-30 | $259.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$6.07K derived: sum of 2 quarters · filed 2015-11-10 | $1.91K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | -$6.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $1.65K 10-Q · filed 2015-08-11 | ||
| 2015-03-31 | $7.98K 10-Q · filed 2015-05-11 | |||
| 2014-06-30 | $7.12K 10-Q · filed 2014-08-14 | |||
| 2013-12-31 | $1.42K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |